Home
World Journal of Biology Pharmacy and Health Sciences
ISSN Approved | International, Peer reviewed, Referred, Open access Journal

Main navigation

  • Home
    • Journal Information
    • Abstracting and Indexing
    • Editorial Board Members
    • Reviewer Panel
    • Journal Policies
    • WJBPHS CrossMark Policy
    • Publication Ethics
    • Current Issue
    • Issue in Progress
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Become a Reviewer panel member
    • Join as Editorial Board Member
  • Contact us
  • Downloads

ISSN Approved Journal | | IMPACT FACTOR 8.16 | | eISSN: 2582-5542 | |  Free Crossref DOI 

Fast Publication within 2 days after Acceptance | | Low Article Processing Charges | | Peer Reviewed and Referred Journal

Research and review articles are invited for publication in October 2026 (Volume 28, Issue 1) Submit Paper

Patient-reported adverse events associated with use of anti-hypertensive drugs in a tertiary hospital in southern Nigeria

Breadcrumb

  • Home
  • Patient-reported adverse events associated with use of anti-hypertensive drugs in a tertiary hospital in southern Nigeria

Chibuike Eze Nwafor 1, * and Marvis Somtochukwu Muo 2

1 Cardiology Unit, Department of Medicine, University of Port Harcourt and University of Port Harcourt Teaching Hospital, Nigeria.
2 Research unit, GoodHeart Medical Consultants Hospital, Port Harcourt, Rivers State, Nigeria.

Research Article
 
World Journal of Biology Pharmacy and Health Sciences, 2024, 17(03), 310–316.
Article DOI: 10.30574/wjbphs.2024.17.3.0161
DOI url: https://doi.org/10.30574/wjbphs.2024.17.3.0161

Received on 13 February 2024; revised on 26 March 2024; accepted on 29 March 2024

Background Hypertension is a leading cause of cardiovascular morbidity and mortality worldwide especially in sub-Saharan Africa. Adverse events with use of antihypertensive medications deter patients’ adherence. This study is aimed at evaluating the adverse events and comorbidities associated with the use of antihypertensive as seen in a tertiary hospital in southern Nigeria.
Method This retrospective cross-sectional study was conducted at a tertiary healthcare hospital in southern Nigeria. Data was collected for a period of six months from 194 patients who attended cardiac clinic with demographic details, blood pressure values, antihypertensive drugs in use, level of medication adherence, adverse events, and co-morbidities.

Result Antihypertensive medications were prescribed according to their classes. Telmisartan (ARB) being the most prescribed one. Fixed dose single pill combination was more preferred. Adverse events such as dry cough, peripheral neuropathy, dizziness, peripheral edema, and erectile dysfunction were recorded. Major comorbidities are diabetes mellitus, dyspepsia and hyperlipidemia. Findings revealed gender disparities with males experiencing erectile dysfunction and more.

Conclusion This analysis pinpoints the need for prompt identification of comorbidities and side effects when treating hypertension. Patients’ compliance to treatment and therapy effectiveness is largely dependent on the provision of patient-specific treatment plan.

Adverse effects; Adverse drug reactions; ADR; Comorbidities; Antihypertensives; Drugs; South-south; Nigeria

https://wjbphs.com/sites/default/files/fulltext_pdf/WJBPHS-2024-0161.pdf

Preview Article PDF

Chibuike Eze Nwafor and Marvis Somtochukwu Muo. Patient-reported adverse events associated with use of anti-hypertensive drugs in a tertiary hospital in southern Nigeria. World Journal of Biology Pharmacy and Health Sciences, 2024, 17(03), 310–316. Article DOI: https://doi.org/10.30574/wjbphs.2024.17.3.0161

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content


Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


Copyright © 2026 World Journal of Biology Pharmacy and Health Sciences (WJBPHS) - All rights reserved

Developed & Designed by VS Infosolution